K36 Therapeutics

Kartos Therapeutics

This biopharmaceutical company develops oral small-molecule therapeutics to treat blood cancers and solid tumors for patients with unmet clinical needs.

Kymera Therapeutics

This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.

Khora

This clinical-stage precision oncology company develops targeted small-molecule therapeutics, including CDK and FGFR inhibitors, for patients with diverse cancer types.

MyCural Therapeutics

This company develops small molecule drugs targeting the MYC oncoprotein to treat patients with aggressive, high-risk cancers.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

Ribon Therapeutics

This biotechnology company develops small molecule inhibitors targeting stress support pathways for patients with cancer and inflammatory diseases.

Senex Biotechnology

This drug discovery company develops small-molecule inhibitors targeting gene regulation proteins for pharmaceutical partners and healthcare providers treating prostate and breast cancers.

Kronos Bio

This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.